FindTrial
Sign In

A clinical trial to study the efficacy of the drug misoprostol administered rectally in reducing excessive bleeding after normal delivery

A study to assess the role of rectal misoprostol when combined with standard oxytocin to prevent postpartum haemorrhage in vaginal delivery.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/08/004910
Enrollment
320
Registered
2014-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Women with singleton pregnancy undergoing normal vaginal delivery

Interventions

Intervention1: misoprostol 400 micrograms stat: 400 microgram of misoprostol administered rectally Control Intervention1: Placebo: Lactose tablets

Sponsors

DrSMCSIMedical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women with singleton pregnancy cephalic presentation >28 weeks of gestational age Hb >10gms

Exclusion criteria

Exclusion criteria: patients undergoing cesarean section and instrumental delivery malpresentation multiple pregnancy past history of post partum haemorrhage coagulopathies heart disease/renal disease placenta previa/abruptio placenta

Design outcomes

Primary

MeasureTime frame
fall in haemoglobin and PCV levelsTimepoint: 24 hours—

Secondary

MeasureTime frame
Duration of third stage of labour Timepoint: 1 hour—

Countries

India

Contacts

Public ContactDr Ranjula golda lysander R

Dr.S.M.C.S.I.Medical college

drlnair@gmail.com9447052597

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026